EGFR and neoplasm: In this review we presented evidence for the ErbB/Her receptor family member the EGFR as an important driver of immunoescape by downregulating crucial immune activating signals 1, 2, and 3 and by inducing a metabolic shift of tumor cells to aerobic glycolysis and lactate secretion into the tumor microenvironment.